Jpmorgan Chase & CO Nephros Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Nephros Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 13 shares of NEPH stock, worth $28. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 15
13.33%
Holding current value
$28
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NEPH
# of Institutions
18Shares Held
4.24MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.6MShares$7.78 Million1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA204KShares$440,9810.0% of portfolio
-
Bard Associates Inc Chicago, IL143KShares$309,3570.11% of portfolio
-
Geode Capital Management, LLC Boston, MA90.3KShares$195,0240.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL55.7KShares$120,3330.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $22.3M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...